Status:
COMPLETED
Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Diabetic Peripheral Neuropathy
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The intent of this study is to treat subjects with painful Diabetic Peripheral Neuropathy (DPN) who also have pain on walking and to determine whether or not pregabalin demonstrates improvement relati...
Eligibility Criteria
Inclusion
- Men or women who are at least 18 years old.
- Diagnosis of painful diabetic peripheral neuropathy.
- Pain on walking.
Exclusion
- Inability to walk 50 feet on a flat surface.
- Pain on walking due to conditions other than diabetic peripheral neuropathy.
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT01474772
Start Date
October 1 2011
End Date
July 1 2013
Last Update
January 28 2021
Active Locations (45)
Enter a location and click search to find clinical trials sorted by distance.
1
Dedicated Clinical Research
Goodyear, Arizona, United States, 85395
2
Arizona Research Center
Phoenix, Arizona, United States, 85023
3
Neuro-Pain Medical Center
Fresno, California, United States, 93710
4
HealthCare Partners Medical Group
Los Angeles, California, United States, 90015